Literature DB >> 6153199

The self determinants recognized by human virus-immune T cells can be distinguished from the serologically defined HLA antigens.

W E Biddison, F E Ward, G M Shearer, S Shaw.   

Abstract

The self specificity of human influenza virus-immune cytotoxic T cells has been analyzed in order to clarify the relationship between the self antigens that they recognize and the serologically defined HLA-A and -B antigens. Virus-immune effectors from HLA-A2-positive donors were tested on panels of virus-infected target cells from donors who were either HLA-mismatched or matched only for HLA-A2. Virus-immune T cells from 11 out of 11 A2-positive donors lysed all A2-matched virus-infected target cells (and no HLA-mismatched targets), except that each of these effector cells consistently failed to lyse virus-infected target cells from one A2-positive donor (designated M7). Although the A2 specificity of donor M7 could also be distinguished from the A2 antigen of other donors by alloimmune cytotoxic T cells, no differences in the A2 antigen of donor M7 could be defined by extensive serologic analyses. These results indicate that there is a strong but incomplete association between a self antigen recognized by virus-immune T cells and the serologically defined HLA-A2 specificity.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6153199

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  37 in total

Review 1.  Role of class I molecules of the major histocompatibility complex in cytotoxic T-cell function in health and disease.

Authors:  A J McMichael
Journal:  Springer Semin Immunopathol       Date:  1992

2.  DNA sequence of HLA-A11: remarkable homology with HLA-A3 allows identification of residues involved in epitopes recognized by antibodies and T cells.

Authors:  E P Cowan; M L Jelachich; W E Biddison; J E Coligan
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

3.  Allospecific T cell recognition of HLA-A2 antigens: evidence for group-specific and subgroup-specific epitopes.

Authors:  L E Wallace; M A Houghton; A B Rickinson; M A Epstein; B A Bradley
Journal:  Immunogenetics       Date:  1985       Impact factor: 2.846

4.  An Oriental HLA-A2 subtype is closely related to a subset of Caucasoid HLA-A2 alleles.

Authors:  H Epstein; L J Kennedy; N Holmes
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

5.  Characterization of the HLA-A2.2 subtype: T cell evidence for further heterogeneity.

Authors:  F M Gotch; C Kelly; S A Ellis; L Wallace; A B Rickinson; J van der Poel; M J Crumpton; A J McMichael
Journal:  Immunogenetics       Date:  1985       Impact factor: 2.846

6.  HLA-B37 and HLA-A2.1 molecules bind largely nonoverlapping sets of peptides.

Authors:  B M Carreno; R W Anderson; J E Coligan; W E Biddison
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

Review 7.  Functional sites of human class I MHC molecules: paradigms a dozen?

Authors:  P Parham
Journal:  Immunol Res       Date:  1987       Impact factor: 2.829

8.  DNA sequences of the genes that encode the CTL-defined HLA-A2 variants M7 and DK1.

Authors:  D H Mattson; D E Handy; D A Bradley; J E Coligan; E P Cowan; W E Biddison
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

9.  Human cytotoxic T-lymphocyte recognition of an HLA-A3 gene product expressed on murine L cells: the only human gene product required on the target cells for lysis is the class I heavy chain.

Authors:  E P Cowan; J E Coligan; W E Biddison
Journal:  Proc Natl Acad Sci U S A       Date:  1985-07       Impact factor: 11.205

10.  Transfection into mouse L cells of genes encoding two serologically and functionally distinct bovine class I MHC molecules from a MHC-homozygous animal: evidence for a second class I locus in cattle.

Authors:  P G Toye; N D MacHugh; A M Bensaid; S Alberti; A J Teale; W I Morrison
Journal:  Immunology       Date:  1990-05       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.